Niagen Bioscience Inc (NAGE)

11:00 AM

National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued - GlobeNewswire Inc.

11:00 AM

10:37 AM

Is Niagen Bioscience Inc. stock undervalued vs historical averagesStop Loss & Expert Verified Movement Alerts - newser.com

10:37 AM

10:20 AM

Will Niagen Bioscience Inc. stock go up soon2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

10:20 AM

10:10 AM

Applying sector rotation models to Niagen Bioscience Inc.2025 EndofYear Setup & Technical Pattern Based Signals - newser.com

10:10 AM

09:56 AM

Tools to assess Niagen Bioscience Inc.’s risk profileQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com

09:56 AM

05:46 AM

How Niagen Bioscience Inc. (OCD1) stock trades pre earnings2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com

05:46 AM

04:41 AM

What earnings revisions data tells us about Niagen Bioscience Inc.Weekly Trend Summary & Safe Capital Growth Plans - newser.com

04:41 AM

03:47 AM

Is NAGE's Pullback A Second Chance For Investors? - RTTNews

03:47 AM

01:28 AM

Is Niagen Bioscience Inc. a candidate for recovery playJuly 2025 Review & Fast Gaining Stock Reports - newser.com

01:28 AM

Oct 10, 2025

Niagen Bioscience's (NAGE) Hold (C) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 09, 2025

Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE), - Yahoo Finance

Oct 09, 2025

Oct 09, 2025

What is Roth Capital’s Estimate for NAGE Q3 Earnings? - Defense World

Oct 09, 2025

Oct 09, 2025

When is the best time to exit Niagen Bioscience Inc.Global Markets & Risk Controlled Daily Plans - newser.com

Oct 09, 2025

Oct 09, 2025

Pattern recognition hints at Niagen Bioscience Inc. upsideJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com

Oct 09, 2025

Oct 09, 2025

Full technical analysis of Niagen Bioscience Inc. stockShare Buyback & Capital Protection Trading Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Niagen Bioscience raises 2025 sales outlook on NAD+ market growth By Investing.com - Investing.com Nigeria

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience Raises 2025 Sales Outlook Amid FDA Ruling - TipRanks

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience, Inc. Provides Net Sales Guidance for the Full-Year 2025 - MarketScreener

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience (NAGE) Gains Attention with FDA's NMN Ruling R - GuruFocus

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience (NAGE) Boosts 2025 Sales Forecast - GuruFocus

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience increases full year 2025 net sales outlook to 25% to 30% year-over-year growth - MarketScreener

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience raises 2025 sales outlook on NAD+ market growth - Investing.com

Oct 06, 2025

Oct 06, 2025

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth - Business Wire

Oct 06, 2025

Oct 06, 2025

What margin trends mean for Niagen Bioscience Inc. stockEarnings Beat & Technical Buy Zone Confirmation - newser.com

Oct 06, 2025

Oct 05, 2025

Is Niagen Bioscience Inc. reversing from oversold territoryJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com

Oct 05, 2025

Oct 04, 2025

Roth Capital Issues Pessimistic Estimate for NAGE Earnings - Defense World

Oct 04, 2025

Oct 03, 2025

A Fresh Look at Niagen Bioscience (NAGE) Valuation After Nationwide iCRYO Distribution Expansion - Sahm

Oct 03, 2025

Oct 03, 2025

Roth Capital Lowers Earnings Estimates for Niagen Bioscience - MarketBeat

Oct 03, 2025

Oct 03, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) 25% Cheaper Price Remains In Tune With Revenues - simplywall.st

Oct 03, 2025

Oct 03, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors - 富途牛牛

Oct 03, 2025

Oct 03, 2025

What macro factors could drive Niagen Bioscience Inc. (OCD1) stock higher2025 Market WrapUp & Precise Buy Zone Identification - newser.com

Oct 03, 2025

Oct 02, 2025

Niagen Bioscience's Pharmaceutical-Grade Niagen IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide - MarketScreener

Oct 02, 2025

Oct 02, 2025

Niagen IV now available at over 900 clinics nationwide By Investing.com - Investing.com Canada

Oct 02, 2025

Oct 01, 2025

Niagen Bioscience (NAGE) Expands Product Reach to Over 900 U.S. Clinics - GuruFocus

Oct 01, 2025

Oct 01, 2025

Niagen IV now available at over 900 clinics nationwide - Investing.com India

Oct 01, 2025

Oct 01, 2025

Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide - Yahoo Finance

Oct 01, 2025

Oct 01, 2025

Analyzing Niagen Bioscience (NASDAQ:NAGE) and CureVac (NASDAQ:CVAC) - Defense World

Oct 01, 2025

Sep 30, 2025

Niagen Bioscience (NASDAQ:NAGE) Trading Down 6.4%What's Next? - MarketBeat

Sep 30, 2025

Sep 30, 2025

Brokerages Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Price Target at $13.42 - Defense World

Sep 30, 2025